United States: The Martoma Decision: The Second Circuit Tackles Insider Trading Post-Salman

Last Updated: August 31 2017
Article by David I. Miller, Kenneth I. Schacter and Grant R. MacQueen

The decision could alter the landscape of tipping liability.

The US Court of Appeals for the Second Circuit issued another landmark insider trading opinion on August 23. In United States v. Martoma,1 the Second Circuit loosened the standard required for the government to establish tipping liability, handing the government a significant victory in this key enforcement area. Martoma is the latest in a string of important decisions concerning this scope of insider trading liability.

In Dirks v. SEC,2 the US Supreme Court established tipping liability, holding that a tippee can be derivatively liable for insider trading when the tipper breached a fiduciary duty by disclosing the inside information. The Court found that whether an insider breached a fiduciary duty hinges on "whether the [tipper] personally will benefit, directly or indirectly, from his disclosure."3 The Court explained that such a benefit includes "when an insider makes a gift of confidential information to a trading relative or friend" because "[t]he tip and trade resemble trading by the insider himself followed by a gift of the profits to the recipient."4

The seeds of Martoma were planted in the Second Circuit's 2014 decision in United States v. Newman,5 which threw a wrench in the government's multiyear enforcement efforts in insider trading because of the decision's heightened standard for tipping liability. Newman redefined the personal-benefit standard to require a "meaningfully close relationship" that presented "at least a potential gain of a pecuniary or similarly valuable nature."6 But then, in December 2016, the Supreme Court issued its first insider trading decision in almost 20 years in United States v. Salman.7 As described below, the Supreme Court abrogated Newman's personal benefit pecuniary requirement by finding—following Dirks—that an insider who gifts inside information to a trading relative or friend receives the requisite personal benefit.

A dispute, however, remained as to whether any gift sufficed or whether a close personal relationship in a gift-giving context was necessary to satisfy the personal-benefit requirement. Martoma resolves that issue, clarifying that so long as someone gifts the inside information with the expectation that the tippee will trade, the personal benefit test is met, even if the tipper and tippee are not even friends or relatives. This is a significant victory for the government.

The Newman Decision

In Newman, defendants Todd Newman and Anthony Chiasson were "remote" or "downstream" tippees convicted of trading on material nonpublic information (MNPI) that they received from other tippees. On appeal, the Second Circuit reversed both convictions. The court held that a tippee only knows of the tipper's breach of fiduciary duty and is therefore potentially liable for insider trading if "he knew the information was confidential and divulged for personal benefit."8 The court further held that a personal benefit cannot be inferred "by the mere fact of a friendship"; rather, it must be established through "proof of a meaningfully close relationship that generates an exchange that is objective, consequential, and that represents at least a potential gain of a pecuniary or similarly valuable nature."9

The Salman Decision

In Salman, defendant Bassam Yacoub Salman, a remote tippee, received and traded on MNPI from his brother-in-law Michael Kara, who had obtained the information from his older brother Maher Kara, an investment banker at a large bank. Evidence showed that Salman was aware that the MNPI originated with Maher Kara, but there was no evidence that Maher received any pecuniary benefit for his tips. Salman was convicted at trial and his conviction was upheld by the US Court of Appeals for the Ninth Circuit. The US Supreme Court granted certiorari.

The Supreme Court squarely rejected Salman's argument that an insider must receive a pecuniary quid pro quo from a tippee to establish a personal benefit. The Court observed that Dirks made clear that a tipper breaches a fiduciary duty—and receives a personal benefit—by making a gift of confidential information to a "trading relative or friend," which clearly happened in that case. In applying Dirks, the Court held that "Maher, a tipper, provided inside information to a close relative, his brother Michael. Dirks makes clear that a tipper breaches a fiduciary duty by making a gift of confidential information to 'a trading relative,' and that rule is sufficient to resolve the case at hand."10

The Court also found that "[t]o the extent the Second Circuit [in Newman] held that the tipper must also receive something of a 'pecuniary or similarly valuable nature' in exchange for a gift to family or friends, Newman, 773 F.3d at 452, we agree with the Ninth Circuit that this requirement is inconsistent with Dirks."11 The Court held that Salman's jury was properly instructed that a personal benefit includes the benefit one would obtain from simply making a gift of confidential information to a trading relative, and, accordingly, upheld the Ninth Circuit's judgment.

The Martoma Case

Mathew Martoma worked as a portfolio manager at S.A.C. Capital Advisors, LLC (SAC), focusing on pharmaceutical and healthcare companies. In that role, Martoma caused SAC to acquire shares of two companies that were jointly developing an experimental drug called bapineuzumab used to treat Alzheimer's disease. Martoma obtained information about bapineuzumab from Dr. Sidney Gilman, chair of the safety monitoring committee for the bapineuzumab clinical trial, in meetings arranged by an expert networking firm. Dr. Gilman participated in approximately 43 consultations with Martoma, for some of which he was paid $1,000 per hour. Despite his obligation to keep the results of the clinical trial confidential, Dr. Gilman disclosed test results and other confidential information to Martoma during the consultations. On July 17 and 19, 2008, in advance of a July 29, 2008 conference at which Dr. Gilman was due to present bapineuzumab test results, Dr. Gilman and Martoma met. Shortly thereafter, on July 21, 2008, SAC began to reduce its positions in the two companies at issue through short sales and options trades. On July 29, 2008, immediately following Dr. Gilman's presentation, the share prices of the two companies at issue fell significantly. The trades that SAC had made in advance of the presentation resulted in approximately $80 million in gains and $195 million in averted losses.

Martoma was indicted for insider trading in the Southern District of New York, and on September 9, 2014, following a four-week trial at which Dr. Gilman testified, Martoma was convicted. While Martoma's appeal was pending, the Second Circuit decided Newman and, after the Second Circuit heard oral argument in the Martoma appeal, the Supreme Court decided Salman. The Second Circuit requested additional briefing.

On appeal, Martoma argued that (i) the evidence presented at trial was insufficient to support his conviction and (ii) the district court did not properly instruct the jury in light of the Second Circuit's decision in Newman. As to the sufficiency argument, Martoma argued that he and Dr. Gilman did not have a "meaningfully close personal relationship" and that Dr. Gilman had not received any pecuniary or similarly valuable gain in exchange for providing Martoma with confidential information.12 As to the second ground for appeal, Martoma argued that Newman's personal benefit holding, requiring a "meaningfully close personal relationship" when a gift is made by an insider to a tippee, survived Salman, and the Martoma jury was not properly instructed on it.13

Martoma's Majority Opinion

As to Martoma's sufficiency challenge, the majority found that even though Dr. Gilman did not bill Martoma for the two July 2008 meetings at which Dr. Gilman provided Martoma with the critical bapineuzumab testing information, Dr. Gilman and Martoma maintained a quid pro quo relationship that presented the opportunity to "yield future pecuniary gain."14 As to that relationship, the court noted that "Martoma was a frequent and lucrative client for Dr. Gilman," and "[a]t the same time, Dr. Gilman was regularly feeding Martoma confidential information about the safety results of clinical trials involving bapineuzumab."15 The court held that in the context of Dr. Gilman's ongoing quid pro quo relationship, where Dr. Gilman regularly disclosed confidential information in exchange for fees, a rational trier of fact could have found the essential elements of insider trading under a pecuniary quid pro quo theory.16

As to Martoma's jury instruction challenge, the majority held that even though Salman did not explicitly reject Newman's "meaningfully close personal relationship" requirement, the logic of Salman abrogated it. The court reasoned that "the straightforward logic of the gift-giving analysis in Dirks, strongly reaffirmed in Salman, is that a corporate insider personally benefits whenever he discloses inside information as a gift with the expectation that the recipient would trade on the basis of such information or otherwise exploit it for his pecuniary gain."17 The court reasoned that this is so because "such a disclosure is the functional equivalent of trading on the information himself and giving a cash gift to the recipient."18 The court thus held that "an insider or tipper personally benefits from a disclosure of inside information whenever the information was disclosed with the expectation that the recipient would trade on it, and the disclosure resembles trading by the insider followed by a gift of the profits to the recipient, whether or not there was a meaningfully close personal relationship between the tipper and tippee."19

Having concluded that Newman's "meaningfully close personal relationship" requirement is no longer good law, the court considered whether the district court's jury instructions were accurate. The court held that the district court's jury instructions did not constitute obvious error, and held that even if the jury instructions were obviously erroneous, that error did not impair Martoma's substantial rights in light of the "compelling evidence that Dr. Gilman, the tipper, received substantial financial benefit in exchange for providing confidential information to Martoma."20

Judge Pooler's Dissent

Judge Rosemary S. Pooler issued a lengthy dissent criticizing various aspects of the majority opinion.21 Judge Pooler characterized the majority opinion as holding that "an insider receives a personal benefit when the insider gives inside information as a 'gift' to any person."22 Judge Pooler reasoned that Newman included two holdings: (i) "when the government wishes to show a personal benefit based on a gift within a friendship, as permitted by Dirks, the friendship must be 'a meaningfully close personal relationship,'"23 and (ii) "an insider's gift to a friend only amounted to a personal benefit if the gift might yield money (or something similar) for the insider."24 Judge Pooler opined that Salman overturned only the second of those holdings, and she further asserted that the majority's requirement that a tipper must expect the tippee to trade on the information provided is not dispositive because that requirement always exists in tipping cases.25

One thing the majority and the dissent agreed on was that Salman expressly rejected Newman's requirement that the relationship between tipper and tippee "generate an exchange that is objective, consequential, and represents at least a potential gain of a pecuniary or similarly valuable nature."26

The Decision's Implications

The Martoma decision is significant for several reasons. As the Second Circuit noted, "[t]his appeal is our first occasion to consider Newman in the aftermath of the Supreme Court's recent decision in [Salman]."27 The Second Circuit found that Newman's requirement of a close relationship between tipper and tippee does not stand in light of Salman. Indeed, the Second Circuit clarified that so long as someone gifts the inside information with the expectation that the tippee will trade, the nature of the relationship between the tipper and the tippee does not matter. Thus, absent a rehearing en banc or grant of certiorari, the Second Circuit has provided additional gloss on the "gift theory" articulated in Dirks, holding that any gift suffices and focusing the relevant inquiry on whether a tipper expects that a tippee will trade on the inside information provided. Unless the panel's decision in Martoma is overturned, the ambiguity and limitations created by Newman's personal benefit test are all but gone and Martoma will significantly aid the government's insider trading enforcement efforts.


1 United States v. Martoma, No. 14-3599, Dkt. No. 174-1 (2d Cir. Aug. 23, 2017).

2 463 U.S. 646 (1983).

3 Id. at 662.

4 Id. at 664.

5 773 F.3d 438 (2d Cir. 2014).

6 Id. at 452.

7 137 S. Ct. 420 (2016).

8 773 F.3d 438, 450.

9 Id. at 452.

10 137 S. Ct. 420, 427.

11 Id. at 428.

12 Martoma, slip op. at 13.

13 Martoma, slip op. at 19.

14 Martoma, slip op. at 18 (quoting Newman, 773 F.3d at 452).

15 Martoma, slip op. at 18.

16 Martoma, slip op. at 18-19.

17 Martoma, slip op. at 25 (internal quotations, citations, and alterations omitted).

18 Martoma, slip op. at 25.

19 Martoma, slip op. at 27-28 (internal quotations, citations, and alterations omitted).

20 Martoma, slip op. at 35.

21 United States v. Martoma, No. 14-3599, Dkt. No. 175 (2d Cir. Aug. 23, 2017) (Pooler, J., dissenting) (hereinafter, Dissent).

22 Dissent at 2.

23 Dissent at 11.

24 Dissent at 13.

25 Dissent at 20 (citing S.E.C. v. Obus, 693 F.3d 276, 286-87 (2d Cir. 2012); United States v. Gansman, 657 F.3d 85, 92 (2d Cir. 2011)).

26 Martoma, slip op. at 22 n.6; Dissent at 15, 18.

27 Martoma, slip op. at 3.

This article is provided as a general informational service and it should not be construed as imparting legal advice on any specific matter.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.